← Back to Vaccine Database

MTBVAC

Live attenuated vaccine · VDDBV0513

Target & Classification

HIVHuman immunodeficiency virus
Live attenuated vaccine
HIV Infections
Phase 3

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials2

NCT IDPhaseDisease / Condition
NCT02013245 Phase 1HIV Infections
NCT04975178 Phase 3HIV Infections